Skip to main content

Table 1 Demographic data in all 910 patients with COVID-19 pneumonia and correlation with prognosis in 320 patients

From: Correlation between the initial CT chest findings and short-term prognosis in Egyptian patients with COVID-19 pneumonia

  All patients (910) Stable patients (127/320) Hospitalized stable patients (93/320) Patients needed ICU (72/320) Died (28/320) P value
Age       
 Median 55.2 36.5 42.4 51.4 57.7  < 0.01
 Range (19–90) (19–72) (34–71) (40–75) 38–87  
Gender       
 Male 528(58.02%) 61 (48.03%) 57 (61.29%) 38 (52.77%) 17(60.71%)  > 0.05
 Female 382 (41.97%) 65 (51.18%) 36 (38.79%) 34 (47.22%) 11(39.28%)  
Clinical       
 Fever 802 (88.13%) 102(80.03%) 87 (93.54%) 68 (94.44%) 28 (100%) 0.651
 Cough 765 (84.06%) 97(76.3%) 65 (69.89%) 65 (90.27%) 26 (92.85%) 0.45
 Dyspnea 412 (45.27%) 19(14.96) 56 (60.21%) 54 (75.00%) 28(100%)  < 0.05
 Sore throat 350 (38.46%) 28(22.04%) 38 (40.86%) 23(31.94%) 11(39.28%) 0.541
 GIT symptoms 137 (15.05%) 35(27.55%) 23 (24.73%) 18 (25.00%) 8 (28.57%) 0.432
 Muscle pain 522 (57.36%) 58 (45.66%) 54 (58.06%) 61 (84.72%) 22 (78.5%) 0.58
Laboratory investigations       
 SP O2 (%) 91 (62–99) 93 (80–99) 88 (75–98) 72 (80–99) 69 (62–81) 0.01
 Lymphocytes (%) 14.8% (3.2–49.5) 15.2(6–49.5) 12.2(4.4–45.5) 10.2(5.3–40.5) 8.2(3.2–11.45) 0.07
 CRP (mg/dL) 13.54 (1.1–52.16) 7.5(1.1–16.3) 11.5(8.2–46.3) 16.5(8.1–36.3) 18.5(9.1–52.16) 0.01
 D-Dimer (mg/L) 0.95 (0.27–33.2) 0.71(0.28–9.3) 0.99 (0.3–15.3) 1.1 (1.8–7.3) 2.3(1.21–13.3)  < 0.05
 Leucocytes (103 µL) 5.91 (2.1–19.12) 4.5(3.3–17.2) 8.5 (2.1–12.2) 7.5(5.4–19.12) 11.5(7.3–12.2) 0.56
 S creatinine (mg/dL) 0.87 (0.50–8.26) 0.75(0.50–1.4) 0.81(0.61–1.9) 1.5 (0.80–8.2) 2.15 (0.50–1.4) 0.01
 Bilirubin (mg/dL) 0.40 (0.2–4.8) 0.3 (0.2–1.1) 1.1(0.4–2.1) 0.8 (1.2–3.1) 0.9 (1.4–4.8) 0.65
Co-morbidities       
 Diabetes 166 (18.2%) 64 (50.39%) 31 (33.3%) 49 (68.05%) 13 (46.4%) 0.07
 Hypertension 171 (18.7%) 62 (48.81%) 34 (36.95%) 57 (79.16%) 9 (32.1%) 0.08
 Heart disease 49 (5.3%) 18 (14.17%) 16 (17.20%) 11 (15.27%) 4 (14.28%) 0.61
 COPD /chest 43 (4.7%) 15 (11.81%) 12 (12.90%) 10 (13.8%) 6 (21.4%) 0.54
 Neurological 31 (3.4%) 13 (10.23%) 9 (9.6%) 5 (6.9%) 4 (14.2%) 0.27